SCNX Scienture Holdings Inc.

$SCNX *REZENOPY™ selling commercially at 2000 clinics currently *Arbli selling commercially as of last week to the formularies of three U.S. pediatric academic medical centers and hospitals- high margins, gaining momentum * $6 mil market cap - Share Count: ~1,642,565 shares

$SCNX just dumped most of my shares sorry.. this is what happens when you invest in a company with as CEO name shankar

$SCNX Monday 10/12 is our compliance deadline. Hopefully there aren't any issues since we will only have been above $1.0 for 5 days.

$SCNX I know they are splitting on Monday, and I know the company is dumping shares, they all do. But this is a $6 mil market cap and thats a very good PR, revenues and sales are exploding. I'm buying.

$SCNX Don't forget, we're still facing the dilemma of only being above $1 for 5 consecutive trading days by the October 12th compliance deadline, instead of the requisite 10 consecutive trading days.

$SCNX RSI at 8 - this low volume premartket dip is impatient kids who bid dumped, this is the sort of trading that always loses money

$SCNX BIG Market Opportunity: EPANED from Azurity Pharma (~$43M peak) validated the demand for liquid antihypertensives, but Arbli™ (Losartan) targets a 24x larger patient base with a modern, FDA-approved ARB formulation. Operational Advantages: Arbli™ eliminates cold-chain logistics with 24-month room-temperature stability, features a taste-masked peppermint flavor for better compliance, and replaces error-prone compounding in hospitals. Long-Term Exclusivity: Backed by robust US patents securing exclusivity through October 2041, Arbli™ provides a fully protected, long-term runway for high-margin growth.

$SCNX Possible PR on Tuesday pre market with a pontial of huge volume and explosive price movement. If true, this is a last chance to buy today. GLTA.

$SCNX inked an exclusive REZENOPY distribution deal reaching ~2,000 U.S. addiction treatment clinics.

$SCNX I closed my position with a loss. Had high hopes on this one... Good luck for everyone who are still holding ✌️

$SCNX an average OTP clinic uses between 100 and 500 doses anually. So let’s be conservative and take 100 doses. 2000x100= 200k doses annually. So given that 1 dose costs 20$ (guesstimate) this should bring $4M a year.

$SCNX this may be the best time to own this stock since last September. These only pump when no one is on the ride. By time anyone hears about it, they’ve already missed most of the pump. Fingers crossed for all the fellow longs but big volume day is going to skyrocket this stock. Have to be ready to sell as they will dilute that run up in a hurry. Just my opinion.

$SCNX I expect there going to pump the shxt out of this soon after RS takes effect, then they'll kneecap all the chasers. I might buy 50k right before the close today hoping for a quick 100% whan-bam thank you ma'am next week. I've seen it before.

$SCNX I had some luck with this one in the past. Jumping in for 20k share starter at .14. Last time I sold way too early, even though I doubled my money. I’ll be happy with .21 this time around. Not delusional though. Definitely could lose the whole 2800 investment as well.

$SCNX Arbli™ addresses a large and established U.S. losartan market representing approximately $219 million in sales and approximately 72 million prescriptions annually (IQVIA MAT Apr 2026). By eliminating the variability and inconvenience associated with pharmacy compounding, Scienture believes that Arbli™ provides healthcare professionals with a consistent, convenient and scalable ready-to-use treatment option.

$SCNX with all the shorts on board this is like a coiled spring. Volume until now 139m vs 2.9m avg volume!

$SCNX What I’m hoping for is a 1,000% spike in premarket that actually holds. I don’t want those fake-ass momentum pumpers showing up, killing the momentum, and then acting like they called it all along with the “I told you so” and “follow me for more” bullshit. 😂

$SCNX SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner!!!

$SCNX SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner

$SCNX i don't know about you but I still have hope here and add some more today! Now 370k @ .2739